EBO Shares EBOS Group Limited
BUY ASX · ASXDefensive healthcare distribution, expected positive trading update, and reliable cash generation support valuation resilience.
Future value: $23.19 (+40.18%) · 6-12 months · analyst consensus
Signal breakdown
- ▸Expected positive trading update and defensive healthcare exposure
- ▾Below 50-day MA (-0.35%)
- ▾Near 52-week low (15% of range)
- ▸~40% upside to price target
Is EBO a buy right now?
Trend: EBO is trading above the 50-day average (+0.48%), RSI 31 — neutral momentum, with a 3-month return of -10.15%.
Valuation & quality: EBOS Group Limited trades on a trailing P/E of 14.4, forward P/E 12.4, PEG 4.39, price-to-book 1.25; fundamentals show net margin 1.7%, return on equity 8.3%, revenue growth 7.1% year on year.
Analyst consensus: 5 analysts have a mean 12-month price target of A$22.81 (+37.9% vs the last close; range A$20.00 – A$26.00), consensus rating “buy”.
Income: trailing dividend yield 5.13%.
Our screen: BUY (score 2) — Defensive healthcare distribution, expected positive trading update, and reliable cash generation support valuation resilience.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -7.20% | -6.90% | -5.80% | +4.80% | +9.00% | -6.40% | -9.50% | +5.70% |
Fundamentals
Analyst price target
Technical signals
About EBOS Group Limited
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through the Healthcare and Animal Care segments.
Sector: Healthcare · Industry: Medical Distribution · Australia · 5,009 employees · Website
Related Health Care picks
Browse: all ASX stocks · Health Care picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.